Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 757, pseudogene (RN7SL757P) is a **pseudogene** present in the human genome and is related to the 7SL RNA, which is the RNA component of the signal recognition particle (SRP) involved in cotranslational protein targeting to the endoplasmic reticulum[3][5][7]. The majority of 7SL-like sequences in the human genome are considered pseudogenes, which are non-functional copies of the original 7SL RNA gene and do not produce functional transcripts or proteins[5][9][6]. Pseudogenes like RN7SL757P generally lack biological activity, and there is no evidence that this specific pseudogene serves as a therapeutic target, biomarker, or has clinically actionable functions. Some pseudogenes can participate in gene regulation through acting as competing endogenous RNAs or by affecting the stability of related gene transcripts, but this has not been shown for RN7SL757P specifically[1][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 757, pseudogene (RN7SL757P).